Library Item - Page 29 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term relationship between bariatric surgery (BS; weight loss surgery) and major adverse cardiovascular events (MACE) in patients with obesity, diabetes, and hypertension (high blood pressure; BP). The study showed that a sustained decrease in MACE occurrence was associated with BS in...

Read More

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Posted by on May 8, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the long-term relationship between bariatric surgery (BS; weight loss surgery) and major adverse cardiovascular events (MACE) in patients with obesity, diabetes, and hypertension (high blood pressure; BP). The study showed that a sustained decrease in MACE occurrence was associated with BS in these patients. Some...

Read More

Evaluating the effectiveness and safety of an all-oral combination of ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma undergoing stem cell transplantation.

Evaluating the effectiveness and safety of an all-oral combination of ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma undergoing stem cell transplantation.

Posted by on May 8, 2022 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of an all-oral combination of ixazomib (Ninlaro), lenalidomide (Revlimid), and dexamethasone (Decadron) in transplant-eligible patients with newly diagnosed multiple myeloma (MM). The data showed that this combination was effective with manageable side effects in these...

Read More

Evaluating the long-term effectiveness and safety of adding carboplatin with or without veliparib to standard chemotherapy given before surgery in patients with triple‑negative breast cancer.

Evaluating the long-term effectiveness and safety of adding carboplatin with or without veliparib to standard chemotherapy given before surgery in patients with triple‑negative breast cancer.

Posted by on May 8, 2022 in Breast cancer | 0 comments

In a nutshell This study reported the long-term effectiveness and safety of adding carboplatin (Paraplatin) with or without veliparib (ABT-888) to standard chemotherapy given before surgery (neoadjuvant chemotherapy; NACT) in patients with early-stage triple-negative breast cancer (TNBC). The data showed that the addition of carboplatin to standard NACT...

Read More

Evaluating the effects of using regular acetaminophen on blood pressure in patients with hypertension.

Evaluating the effects of using regular acetaminophen on blood pressure in patients with hypertension.

Posted by on May 8, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the effects of using regular acetaminophen (Paracetamol) on blood pressure (BP) in patients with hypertension (high BP). The data showed that regular daily acetaminophen use increased BP in these patients and increased the risk of cardiovascular disease when compared with placebo. Some background Hypertension or high...

Read More

Investigating the benefit of frequent surveillance imaging on the survival outcomes in patients with resected stage III melanoma.

Investigating the benefit of frequent surveillance imaging on the survival outcomes in patients with resected stage III melanoma.

Posted by on May 8, 2022 in Melanoma | 0 comments

In a nutshell This study investigated the benefit of frequent surveillance imaging on the survival outcomes in patients with resected stage III melanoma. The data showed that patients who underwent less frequent imaging (12-monthly) had better outcomes than those who underwent more frequent imaging (3- to 4-monthly). Some background Melanoma is a...

Read More

Evaluating the effect of whole grain consumption in blood sugar control of patients with diabetes.

Evaluating the effect of whole grain consumption in blood sugar control of patients with diabetes.

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effect of whole grain consumption in glycaemic (blood sugar) control of patients with diabetes. The data showed that whole grain consumption was beneficial for the control of blood glucose levels in these patients. Some background Diabetes is a condition in which patients have high blood sugar (glucose) levels...

Read More

Evaluating the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease.

Evaluating the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease.

Posted by on May 8, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease (PD). The data showed that in the long-term, the maintenance of high regular physical activity levels and exercise habits were strongly associated with better clinical outcomes of PD symptoms. Some...

Read More

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Is clopidogrel better than ticagrelor in reducing bleeding in stabilized patients with myocardial infarction undergoing percutaneous coronary intervention ?

Posted by on May 8, 2022 in Coronary artery disease | 0 comments

In a nutshell This study investigated if de-escalation (reducing the intensity) of dual antiplatelet therapy (DAPT) with clopidogrel (Plavix) might be better than ticagrelor (Brilique)-based antiplatelet therapy in stabilized patients with acute myocardial infarction (MI; heart attack) undergoing percutaneous coronary intervention (PCI). The data...

Read More

Evaluating the safety and effectiveness of pembrolizumab in combination with rituximab in patients with relapsed or refractory follicular lymphoma.

Evaluating the safety and effectiveness of pembrolizumab in combination with rituximab in patients with relapsed or refractory follicular lymphoma.

Posted by on May 8, 2022 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of pembrolizumab (Keytruda) in combination with rituximab (Rituxan) in patients with relapsed or refractory (r/r) follicular lymphoma (FL). The data showed that pembrolizumab in combination with rituximab was safe and effective in these patients. Some background Follicular lymphoma (FL)...

Read More

Comparing the effectiveness and safety of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Comparing the effectiveness and safety of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Posted by on May 8, 2022 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of abiraterone acetate (Zytiga; AA) and enzalutamide (Xtandi; ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC). The data showed that both medication improve outcomes compared to placebo and ENZ is more effective in improving survival without cancer...

Read More

Evaluating the effectiveness and safety of sugemalimab plus platinum-based chemotherapy for first-line treatment of metastatic squamous and non-squamous non-small cell lung cancer.

Evaluating the effectiveness and safety of sugemalimab plus platinum-based chemotherapy for first-line treatment of metastatic squamous and non-squamous non-small cell lung cancer.

Posted by on May 8, 2022 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety outcomes of sugemalimab (Cejemly) in combination with platinum-based chemotherapy as first-line treatment for patients with metastatic squamous (Sq) and non-squamous (non-Sq) non-small cell lung cancer (NSCLC). The data showed that sugemalimab plus platinum-based chemotherapy...

Read More